Also trades as: PRE (NASDAQ) · $vol 4M
PRENW NASDAQ
Prenetics Global Limited
1W: -40.0%
1M: -38.5%
3M: -33.3%
YTD: -59.6%
1Y: -35.8%
3Y: -97.5%
$0.01
+0.00 (+0.00%)
Weekly Expected Move ±70.2%
$-0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$318.6M
52W Range0.01-0.022
Volume1,358
Avg Volume32,280
Beta0.25
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSheng Wu Yeung
Employees98
SectorHealthcare
IndustryMedical - Diagnostics & Research
IPO Date2021-07-16
Websiteprenetics.com
Unit 701-706, K11 Atelier Kingâs Road
Quarry Bay, HK
HK
Quarry Bay, HK
HK
852 2210 9588
About Prenetics Global Limited
Prenetics Global Limited operates as an investment holding company specializing in diagnostics and genetic testing. Its core offerings include CircleDNA, a consumer genetic testing solution, and the Circle HealthPod, a rapid detection health monitoring system that enables users to perform point-of-care or at-home COVID-19 tests using nucleic acid amplification technology. The company's portfolio further comprises ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an accessible at-home blood testing kit; and Circle Medical, a diagnostic testing platform. Other products include Circle One, F1x, and Fem. Established in 2014, Prenetics Global Limited is headquartered in Quarry Bay, Hong Kong.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Shah Darshan Ravindr | 0 | — | 2026-03-26 | |
| Shah Darshan Ravindr | 5,599 | — | 2026-03-26 | |
| Yeung Danny Sheng Wu | 0 | — | 2026-03-26 | |
| Yeung Danny Sheng Wu | 0 | — | 2026-03-26 | |
| Yeung Danny Sheng Wu | 0 | — | 2026-03-26 |